Can a patient with a left ureteropelvic junction stone and no evidence of hydronephrosis or obstruction be managed with medical therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can a Patient with a Left Ureteropelvic Junction Stone and No Hydronephrosis or Obstruction Be Managed with Medical Therapy?

Yes, a patient with a ureteropelvic junction (UPJ) stone without hydronephrosis or obstruction can be managed with medical expulsive therapy (MET) using alpha-adrenergic blockers if the stone is ≤10 mm, with a trial period of approximately 30 days.

Initial Management Approach

For stones at the UPJ (proximal ureter) without obstruction or hydronephrosis, you have a window for conservative management:

  • Alpha-blockers (tamsulosin, alfuzosin, doxazosin, terazosin, or silodosin) should be offered for stones ≤10 mm 1, 2. The EAU guidelines specifically note the greatest benefit is for stones >5 mm in the ureter 2.

  • The trial period should be approximately 30 days before reassessing 1.

  • Alpha-blockers have been shown to increase spontaneous stone passage rates, reduce pain episodes, decrease need for pain medication, and reduce unplanned healthcare encounters including emergency department visits 1.

Important Caveats

When Medical Therapy May Not Be Appropriate

The absence of hydronephrosis is actually reassuring and supports conservative management. However, you need to monitor for:

  • Development of obstruction or hydronephrosis - If this occurs, more urgent intervention may be needed to prevent irreversible renal function loss 1.

  • Persistent or worsening symptoms despite adequate analgesia.

  • Signs of infection/sepsis - This requires urgent decompression via percutaneous nephrostomy or ureteral stenting 2.

Pain Management During MET

  • NSAIDs (diclofenac, ibuprofen, metamizole) are first-line for renal colic 2.

  • Use the lowest effective dose due to cardiovascular, gastrointestinal, and potential renal function risks 2.

  • Opioids are second-line if NSAIDs are insufficient or contraindicated; avoid pethidine due to high vomiting rates 2.

When to Transition to Surgical Management

If MET fails after 30 days or the patient develops complications, surgical options include:

  • URS (ureteroscopy) or SWL (shock wave lithotripsy) for proximal ureteral stones <2 cm 1. Meta-analyses show URS has higher single-procedure stone-free rates than SWL for proximal stones, though both are acceptable options 1.

  • For stones >2 cm or those failing retrograde approaches, a percutaneous antegrade approach should be offered 1.

Critical Pitfall to Avoid

Do not assume resolution of pain means stone passage 3. A study of 220 patients found that 84% of those with persistent stones at follow-up had no pain, and 53% had neither pain nor hydronephrosis 3. Resolution of hydronephrosis is associated with stone passage (RR 4.6), but resolution of pain is not (RR 1.1) 3. Therefore, imaging follow-up is essential regardless of symptom resolution.

Monitoring Strategy

  • Obtain baseline urine culture before treatment to exclude UTI 2.

  • Follow-up imaging at 4 weeks to assess stone passage, even if asymptomatic.

  • If the stone persists but remains asymptomatic without obstruction, you can extend observation, but discuss surgical options as spontaneous passage becomes less likely over time.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.